Davita Inc vs Synchrony Financial — how do they compare? Davita Inc trades at $179.02 (market cap $11.38B), while Synchrony Financial trades at $78.37 (market cap $25.53B). The key difference: Synchrony Financial is far larger — about 2.2× Davita Inc's market cap, and Synchrony Financial pays a 1.73% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | SYF | |
|---|---|---|
Market Cap | $11.38B | $25.53B |
Sector | Health | Financials |
52-Week High | $240.96 | $88.47 |
52-Week Low | $103.87 | $63.78 |
Enterprise Value | $24.10B | — |
Dividend Yield | — | 1.73% |
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →